II. Department of Medicine

Publications

  1. 2019
  2. Case Report: Apixaban - Behandlung venöser Thrombembolien und Rezidivprophylaxe

    Galow, S. & Klose, H., 06.2019, In: Case Report. 11, Heft 11, p. 6-7

    Research output: SCORING: Contribution to journalNewspaper articlesTransfer

  3. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study

    Ludwig, H., Gascón, P., Bokemeyer, C., Aapro, M., Boccadoro, M., Denhaerynck, K., Krendyukov, A., MacDonald, K. & Abraham, I., 06.2019, In: SUPPORT CARE CANCER. 27, 6, p. 2301-2312 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

    Richardson, P. G., Oriol, A., Beksac, M., Liberati, A. M., Galli, M., Schjesvold, F., Lindsay, J., Weisel, K., White, D., Facon, T., San Miguel, J., Sunami, K., O'Gorman, P., Sonneveld, P., Robak, P., Semochkin, S., Schey, S., Yu, X., Doerr, T., Bensmaine, A., Biyukov, T., Peluso, T., Zaki, M., Anderson, K., Dimopoulos, M. & OPTIMISMM trial investigators, 06.2019, In: LANCET ONCOL. 20, 6, p. 781-794 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

    Facon, T., Kumar, S., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Attal, M., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Ahmadi, T., Chiu, C., Wang, J., Van Rampelbergh, R., Uhlar, C. M., Kobos, R., Qi, M., Usmani, S. Z. & MAIA Trial Investigators, 30.05.2019, In: NEW ENGL J MED. 380, 22, p. 2104-2115 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

    Salwender, H., Bertsch, U., Weisel, K., Duerig, J., Kunz, C., Benner, A., Blau, I. W., Raab, M. S., Hillengass, J., Hose, D., Huhn, S., Hundemer, M., Andrulis, M., Jauch, A., Seidel-Glaetzer, A., Lindemann, H-W., Hensel, M., Fronhoffs, S., Martens, U., Hansen, T., Wattad, M., Graeven, U., Munder, M., Fenk, R., Haenel, M., Scheid, C. & Goldschmidt, H., 28.05.2019, In: BMC CANCER. 19, 1, p. 504

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

    Wei, A. H., Strickland, S. A., Hou, J-Z., Fiedler, W., Lin, T. L., Walter, R. B., Enjeti, A., Tiong, I. S., Savona, M., Lee, S., Chyla, B., Popovic, R., Salem, A. H., Agarwal, S., Xu, T., Fakouhi, K. M., Humerickhouse, R., Hong, W-J., Hayslip, J. & Roboz, G. J., 20.05.2019, In: J CLIN ONCOL. 37, 15, p. 1277-1284 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Impact of taste and smell training on taste disorders during chemotherapy – TASTE trial

    von Grundherr, J., Koch, B., Grimm, D., Salchow, J., Valentini, L., Hummel, T., Bokemeyer, C., Stein, A. & Mann, J., 16.05.2019, In: CANCER MANAG RES. 11, p. 4493—4504 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

    Scharpenseel, H., Hanssen, A., Loges, S., Mohme, M., Bernreuther, C., Peine, S., Lamszus, K., Goy, Y., Petersen, C., Westphal, M., Glatzel, M., Riethdorf, S., Pantel, K. & Wikman, H., 15.05.2019, In: SCI REP-UK. 9, 1, p. 7406

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

    Al-Batran, S-E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H-G., Mayer, F., Haag, G. M., Luley, K., Lindig, U., Schmiegel, W., Pohl, M., Stoehlmacher, J., Folprecht, G., Probst, S., Prasnikar, N., Fischbach, W., Mahlberg, R., Trojan, J., Koenigsmann, M., Martens, U. M., Thuss-Patience, P., Egger, M., Block, A., Heinemann, V., Illerhaus, G., Moehler, M., Schenk, M., Kullmann, F., Behringer, D. M., Heike, M., Pink, D., Teschendorf, C., Löhr, C., Bernhard, H., Schuch, G., Rethwisch, V., von Weikersthal, L. F., Hartmann, J. T., Kneba, M., Daum, S., Schulmann, K., Weniger, J., Belle, S., Gaiser, T., Oduncu, F. S., Güntner, M., Hozaeel, W., Reichart, A., Jäger, E., Kraus, T., Mönig, S., Bechstein, W. O., Schuler, M., Schmalenberg, H., Hofheinz, R. D. & FLOT4-AIO Investigators, 11.05.2019, In: LANCET. 393, 10184, p. 1948-1957 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

    Sebastian, M., Schröder, A., Scheel, B., Hong, H. S., Muth, A., von Boehmer, L., Zippelius, A., Mayer, F., Reck, M., Atanackovic, D., Thomas, M., Schneller, F., Stöhlmacher, J., Bernhard, H., Gröschel, A., Lander, T., Probst, J., Strack, T., Wiegand, V., Gnad-Vogt, U., Kallen, K-J., Hoerr, I., von der Muelbe, F., Fotin-Mleczek, M., Knuth, A. & Koch, S. D., 05.2019, In: CANCER IMMUNOL IMMUN. 68, 5, p. 799-812 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

    Döhner, H., Müller-Tidow, C., Lübbert, M., Fiedler, W., Krämer, A., Westermann, J., Bug, G., Schlenk, R. F., Krug, U., Goeldner, R-G., Hilbert, J., Taube, T. & Ottmann, O. G., 05.2019, In: BRIT J HAEMATOL. 185, 3, p. 583-587 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Atemwegssicherung in der Intensiv- und Notfallmedizin: Was gibt es Neues?

    Grensemann, J., Simon, M. & Kluge, S., 05.2019, In: MED KLIN-INTENSIVMED. 114, 4, p. 334-341 8 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  14. Current pharmacotherapy for testicular germ cell cancer

    Alsdorf, W., Seidel, C., Bokemeyer, C. & Oing, C., 05.2019, In: EXPERT OPIN PHARMACO. 20, 7, p. 837-850 14 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  15. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

    Michel, C., Burchert, A., Hochhaus, A., Saussele, S., Neubauer, A., Lauseker, M., Krause, S. W., Kolb, H-J., Hossfeld, D. K., Nerl, C., Baerlocher, G. M., Heim, D., Brümmendorf, T. H., Fabarius, A., Haferlach, C., Schlegelberger, B., Balleisen, L., Goebeler, M-E., Hänel, M., Ho, A., Dengler, J., Falge, C., Möhle, R., Kremers, S., Kneba, M., Stegelmann, F., Köhne, C-H., Lindemann, H-W., Waller, C. F., Spiekermann, K., Berdel, W. E., Müller, L., Edinger, M., Mayer, J., Beelen, D. W., Bentz, M., Link, H., Hertenstein, B., Fuchs, R., Wernli, M., Schlegel, F., Schlag, R., de Wit, M., Trümper, L., Hebart, H., Hahn, M., Thomalla, J., Scheid, C., Schafhausen, P., Verbeek, W., Eckart, M. J., Gassmann, W., Schenk, M., Brossart, P., Wündisch, T., Geer, T., Bildat, S., Schäfer, E., Hasford, J., Hehlmann, R. & Pfirrmann, M., 05.2019, In: HAEMATOLOGICA. 104, 5, p. 955-962 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma

    Costello, C., Davies, F. E., Cook, G., Vela-Ojeda, J., Omel, J., Rifkin, R. M., Berdeja, J., Puig, N., Usmani, S. Z., Weisel, K., Zonder, J. A., Terpos, E., Spencer, A., Leleu, X., Boccadoro, M., Thompson, M. A., Romanus, D., Stull, D. M. & Hungria, V., 05.2019, In: FUTURE ONCOL. 15, 13, p. 1411-1428 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Niedermolekulare Heparine in der Onkologie: Überblick und Indikationen

    Holstein, K., 05.2019, In: Vasomed. 2019, 3

    Research output: SCORING: Contribution to journalConference article in journalEducation

  18. Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial

    Bixby, D., Noppeney, R., Lin, T. L., Cortes, J., Krauter, J., Yee, K., Medeiros, B. C., Krämer, A., Assouline, S., Fiedler, W., Dimier, N., Simmons, B. P., Riehl, T. & Colburn, D., 05.2019, In: BRIT J HAEMATOL. 185, 3, p. 595-598 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    EMBRACE Collaborators, 15.04.2019, In: NAT COMMUN. 10, 1, p. 1741

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

    Weisel, K. C., Scheid, C., Zago, M., Besemer, B., Mai, E. K., Haenel, M., Duerig, J., Munder, M., Lindemann, H-W., Seckinger, A., Kunz, C., Benner, A., Hose, D., Jauch, A., Salwender, H. & Goldschmidt, H., 08.04.2019, In: BLOOD CANCER J. 9, 4, p. 45

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  21. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types

    Dinkelborg, P. H., Wang, M., Gheorghiu, L., Gurski, J. M., Hong, T. S., Benes, C. H., Juric, D., Jimenez, R. B., Borgmann, K. & Willers, H., 04.2019, In: BREAST CANCER RES TR. 174, 3, p. 605-613 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Nanobody-targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies

    Tintelnot, J., Baum, N., Schultheiss, C., Braig, F., Trentmann, M., Finter, J., Fumey, W., Bannas, P., Fehse, B., Riecken, K., Schütze, K., Bokemeyer, C., Rösner, T., Valerius, T., Peipp, M., Koch-Nolte, F. & Binder, M., 04.2019, In: MOL CANCER THER. 18, 4, p. 823-833 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Positronenemissionstomographie bei Keimzelltumoren des Mannes: Einsatzmöglichkeiten und Grenzen

    Schriefer, P., Hartmann, M., Oechsle, K., Meyer, C. P., Klutmann, S., Fisch, M., Bokemeyer, C. & Oing, C., 04.2019, In: UROLOGE. 58, 4, p. 418-423 6 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  24. Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance

    Horak, P., Weischenfeldt, J., von Amsberg, G., Beyer, B., Schütte, A., Uhrig, S., Gieldon, L., Klink, B., Feuerbach, L., Hübschmann, D., Kreutzfeldt, S., Heining, C., Maier, S., Hutter, B., Penzel, R., Schlesner, M., Eils, R., Sauter, G., Stenzinger, A., Brors, B., Schröck, E., Glimm, H., Fröhling, S. & Schlomm, T., 04.2019, In: CSH MOL CASE STUD. 5, 2

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. TP53 and Prognosis in mCRPC Survival: Biology or Coincidence?

    Rebello, R. J., Oing, C., Gillessen, S. & Bristow, R. G., 15.03.2019, In: CLIN CANCER RES. 25, 6, p. 1699-1701 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Current Advances in Palliative & Hospice Care: Problems and Needs of Relatives and Family Caregivers During Palliative and Hospice Care-An Overview of Current Literature

    Oechsle, K., 12.03.2019, In: Medical sciences (Basel, Switzerland). 7, 3

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  27. Endothelium-Derived Semaphorin 3G Regulates Hippocampal Synaptic Structure and Plasticity via Neuropilin-2/PlexinA4

    Tan, C., Lu, N-N., Wang, C-K., Chen, D-Y., Sun, N-H., Lyu, H., Körbelin, J., Shi, W-X., Fukunaga, K., Lu, Y-M. & Han, F., 06.03.2019, In: NEURON. 101, 5, p. 920-937.e13

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Sexual dimorphism in solid and hematological malignancies

    Ben-Batalla, I., Vargas-Delgado, M. E., Meier, L. & Loges, S., 01.03.2019, In: SEMIN IMMUNOPATHOL. 41, 2, p. 251-263 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  29. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study

    Ludwig, H., Bokemeyer, C., Aapro, M., Boccadoro, M., Gascón, P., Denhaerynck, K., Krendyukov, A., Abraham, I. & MacDonald, K., 03.2019, In: FUTURE ONCOL. 15, 8, p. 897-907 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

    Fenner, M., Oing, C., Dieing, A., Gauler, T., Oechsle, K., Lorch, A., Hentrich, M., Kopp, H-G., Bokemeyer, C. & Honecker, F., 03.2019, In: J CANCER RES CLIN. 145, 3, p. 717-723 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

    Schlenk, R. F., Weber, D., Fiedler, W., Salih, H. R., Wulf, G., Salwender, H., Schroeder, T., Kindler, T., Lübbert, M., Wolf, D., Westermann, J., Kraemer, D., Götze, K. S., Horst, H-A., Krauter, J., Girschikofsky, M., Ringhoffer, M., Südhoff, T., Held, G., Derigs, H-G., Schroers, R., Greil, R., Grießhammer, M., Lange, E., Burchardt, A., Martens, U., Hertenstein, B., Marretta, L., Heuser, M., Thol, F., Gaidzik, V. I., Herr, W., Krzykalla, J., Benner, A., Döhner, K., Ganser, A., Paschka, P. & Döhner, H., 21.02.2019, In: BLOOD. 133, 8, p. 840-851 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Aspergillus Tracheobronchitis in Influenza B

    Frings, D. P., Simon, M. & Kluge, S., 08.02.2019, In: DTSCH ARZTEBL INT. 116, 6, p. 100

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  33. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

    Georgouli, M., Herraiz, C., Crosas-Molist, E., Fanshawe, B., Maiques, O., Perdrix, A., Pandya, P., Rodriguez-Hernandez, I., Ilieva, K. M., Cantelli, G., Karagiannis, P., Mele, S., Lam, H., Josephs, D. H., Matias-Guiu, X., Marti, R. M., Nestle, F. O., Orgaz, J. L., Malanchi, I., Fruhwirth, G. O., Karagiannis, S. N. & Sanz-Moreno, V., 07.02.2019, In: CELL. 176, 4, p. 757-774.e23

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells

    Brandt, A., Matschke, J., Fehrle, W., von Wenserski, L., Bokemeyer, C., Illerhaus, G. & Binder, M., 02.2019, In: LEUKEMIA LYMPHOMA. 60, 2, p. 334-340 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study

    Hütter-Krönke, M. L., Fiedler, W., Kündgen, A., Krauter, J., von Lilienfeld-Toal, M., Döhner, H. & Schlenk, R., 02.2019, In: HAEMATOLOGICA. 104, 2, p. E63-E64

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  36. Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications

    Voigtländer, M. & Langer, F., 02.2019, In: HAMOSTASEOLOGIE. 39, 1, p. 67-75 9 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  37. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

    Cortes, J. E., Heidel, F. H., Hellmann, A., Fiedler, W., Smith, B. D., Robak, T., Montesinos, P., Pollyea, D. A., DesJardins, P., Ottmann, O., Ma, W. W., Shaik, M. N., Laird, A. D., Zeremski, M., O'Connell, A., Chan, G. & Heuser, M., 02.2019, In: LEUKEMIA. 33, 2, p. 379-389 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

    Beyer-Westendorf, J., Klamroth, R., Kreher, S., Langer, F., Matzdorff, A. & Riess, H., 18.01.2019, In: DTSCH ARZTEBL INT. 116, 3, p. 31-38 8 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  39. Antikoagulatorische Therapie bei onkologischen Patienten

    Voigtländer, M., Lennartz, M., Yamamura, J. & Langer, F., 01.2019, In: Journal Onkologie. 2019, 1, p. 62-70

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

    Retz, M., Bedke, J., Bögemann, M., Grimm, M-O., Zimmermann, U., Müller, L., Leiber, C., Teber, D., Wirth, M., Bolenz, C., van Alphen, R., De Santis, M., Beeker, A., Lehmann, J., Indorf, M., Frank, M., Bokemeyer, C. & Gschwend, J. E., 01.2019, In: EUR J CANCER. 107, p. 37-45 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. 3D in vitro system for measuring treatment responses to immunotherapy in CRC patients

    Sturmheit, T., Stamm, H., Sutus Temovski, T., Konczalla, L., Brauneck, F., Stange, I., Köllmann, S., Li, J., Perez, D., thastrup, J., Wellbrock, J., Fiedler, W., Kupper, J. & Block, A., 2019, In: J CLIN ONCOL.

    Research output: SCORING: Contribution to journalConference abstract in journalResearchpeer-review

  42. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

    Löffler, M. W., Nussbaum, B., Jäger, G., Jurmeister, P. S., Budczies, J., Pereira, P. L., Clasen, S., Kowalewski, D. J., Mühlenbruch, L., Königsrainer, I., Beckert, S., Ladurner, R., Wagner, S., Bullinger, F., Gross, T. H., Schroeder, C., Sipos, B., Königsrainer, A., Stevanović, S., Denkert, C., Rammensee, H-G., Gouttefangeas, C. & Haen, S. P., 2019, In: FRONT IMMUNOL. 10, p. 2526

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Awareness of predatory journals and open access among medical oncologists: results of an online survey

    Richtig, G., Richtig, E., Böhm, A., Oing, C., Bozorgmehr, F., Kruger, S., Kiesewetter, B., Zielinski, C. & Berghoff, A. S., 2019, In: ESMO OPEN. 4, 6, p. e000580

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling

    Tintelnot, J., Metz, S., Trentmann, M., Oberle, A., von Wenserski, L., Schultheiß, C., Braig, F., Kriegs, M., Fehse, B., Riecken, K., Bokemeyer, C., Stein, A. & Binder, M., 2019, In: FRONT ONCOL. 9, p. 1559

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Die Bedeutung der Lebensqualität für Therapieentscheidungen am Lebensende

    Oechsle, K., 2019, In: Gynäkologische Praxis. 44, p. 1-6

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Ethische und rechtliche Aspekte: Sterbehilfe

    Scherg, A. & Oechsle, K., 2019, FAQ Palliativmedizin: Antworten - prägnant und praxisnah. Oechsle, K. & Scherg, A. (eds.). 1 ed. München: Urban & Fischer, p. 261-266 6 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducationpeer-review

  47. Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia

    Engel, N. W., Schliffke, S., Schüller, U., Frenzel, C., Bokemeyer, C., Kubisch, C. & Lessel, D., 2019, In: FRONT ONCOL. 9, p. 420

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Forschung in der Palliativversorgung in Deutschland: aktuelle Situation, Perspektiven und Grenzen?

    Oechsle, K., 2019, In: Z PALLIATMEDIZIN. 2019, 20, p. 79 -88 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Frühe Integration von Palliativversorgung - was wirklich diskutiert werden sollte

    Oechsle, K., 2019, In: Karger Kompass Onkologie. 6, p. 94-95

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Education

  50. Grundlagen: Angehörige

    Oechsle, K. & Ullrich, A., 2019, FAQ Palliativmedizin: Antworten - prägnant und praxisnah. Oechsle, K. & Scherg, A. (eds.). 1 ed. München: Urban & Fischer, p. 24-28 5 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducationpeer-review

  51. Grundlagen: Prinzipien der Palliativmedizin

    Oechsle, K., 2019, FAQ Palliativmedizin: Antworten - prägnant und praxisnah. Oechsle, K. & Scherg, A. (eds.). 1 ed. München: Urban & Fischer, p. 1-9 10 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducationpeer-review